Clearmind Medicine (CMND) Receivables (2021 - 2026)
Clearmind Medicine (CMND) posted quarterly Receivables of $551693.0 for Q2 2026, up 204.26% year-over-year from $181321.0 in Q2 2025, and up 26.06% quarter-over-quarter from $437642.0 in Q1 2026.
Clearmind Medicine (CMND) Receivables (2021 - 2026) Analysis & Trends
Clearmind Medicine's Receivables history runs 6 years deep, the most recent figure standing at $551693.0 for Q2 2026.
- In Q2 2026, Receivables rose 204.26% year-over-year to $551693.0; the TTM figure through Apr 2026 stood at $551693.0 (up 204.26% YoY), while the FY2025 annual figure was $322313.0, up 78.19% from the prior year.
- Receivables for Q2 2026 stood at $551693.0, up from $437642.0 in the prior quarter.
- The five-year high for Receivables was $551693.0 in Q2 2026, with the low at $34721.0 in Q1 2023.
- The 5-year median for Receivables is $209934.0 (2025), against an average of $263114.3.
- Peak annual rise in Receivables reached 343.17% in 2024, while the deepest fall reached 61.68% in 2024.
- Clearmind Medicine's Receivables stood at $342934.1 in 2022, then grew by 13.96% to $390808.0 in 2023, then plunged by 53.72% to $180877.0 in 2024, then surged by 78.19% to $322313.0 in 2025, then jumped by 71.17% to $551693.0 in 2026.
- Business Quant data shows CMND's Receivables at $551693.0 in Q2 2026, $437642.0 in Q1 2026, and $322313.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - | 3,818.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 551,693.00 |
| Jan 31, 2026 | 437,642.00 |
| Oct 31, 2025 | 322,313.00 |
| Jul 31, 2025 | 210,987.00 |
| Apr 30, 2025 | 181,321.00 |
| Jan 31, 2025 | 209,934.00 |
| Oct 31, 2024 | 180,877.00 |
| Jul 31, 2024 | 191,342.00 |
| Apr 30, 2024 | 174,528.00 |
| Jan 31, 2024 | 153,873.00 |
| Oct 31, 2023 | 390,808.00 |
| Jul 31, 2023 | 108,255.00 |
| Apr 30, 2023 | 455,487.00 |
| Jan 31, 2023 | 34,720.98 |
| Oct 31, 2022 | 342,934.08 |
| Oct 31, 2021 | 127,958.89 |